L218-0055 Screening compound: ethyl 4-({2-[4-oxo-2-(4-pyridyl)pyrimido[1,2-a][1,3]benzimidazol-10(4H)-yl]acetyl}amino)benzoate

L218-0055 Screening compound: ethyl 4-({2-[4-oxo-2-(4-pyridyl)pyrimido[1,2-a][1,3]benzimidazol-10(4H)-yl]acetyl}amino)benzoate
L218-0055 Screening compound: ethyl 4-({2-[4-oxo-2-(4-pyridyl)pyrimido[1,2-a][1,3]benzimidazol-10(4H)-yl]acetyl}amino)benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound L218-0055
ethyl 4-({2-[4-oxo-2-(4-pyridyl)pyrimido[1,2-a][1,3]benzimidazol-10(4H)-yl]acetyl}amino)benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L218-0055

Molecular Formula

C26H21N5O4 (C26 H21 N5 O4)

Compound Name

ethyl 4-({2-[4-oxo-2-(4-pyridyl)pyrimido[1,2-a][1,3]benzimidazol-10(4H)-yl]acetyl}amino)benzoate

IUPAC name

ethyl 4-{2-[13-oxo-11-(pyridin-4-yl)-1810-triazatricyclo[7.4.0.0^{27}]trideca-246911-pentaen-8-yl]acetamido}benzoate

SMILES

CCOC(c(cc1)ccc1NC(CN(c(cccc1)c1N12)C2=NC(c2ccncc2)=CC1=O)=O)=O

InChI

InChI=1S/C26H21N5O4/c1-2-35-25(34)18-7-9-19(10-8-18)28-23(32)16-30-21-5-3-4-6-22(21)31-24(33)15-20(29-26(30)31)17-11-13-27-14-12-17/h3-15H,2,16H2,1H3,(H,28,32)

InChI Key

CDMXKNKFQRNTQK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD18171618

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

467.48

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.025

Distribution Coefficient, logD

3.025

Water Solubility, LogSw

-3.22

Polar Surface Area

81.415

Acid Dissociation Constant (pKa)

11.18

Base Dissociation Constant (pKb)

2.13

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

11.50

L218-0055 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

Integrin Receptors Targeted library (1715 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Kinases
  • Others
  • Proteases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L218-0055 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L218-0055?
Check Price and Availability of L218-0055, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L218-0055 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L218-0055
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L218-0055
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L218-0055 available by request